Tiny Cargo Co

Tiny Cargo Co is a biotechnology company specializing in the development of milk-derived exosomes for the oral delivery of therapeutic compounds. Spun out of the Fralin Biomedical Research Institute at Virginia Tech, the company leverages bovine extracellular vesicles (bEVs) to protect fragile drugs, such as peptides and nucleic acids, from degradation in the digestive tract. Their platform aims to transform treatments that currently require injection into convenient oral therapies. The company's technology focuses on high-yield, scalable production of these natural nanocarriers to improve bioavailability and patient compliance across various indications. By utilizing a naturally occurring transport mechanism, Tiny Cargo Co seeks to overcome the traditional barriers of the gut-blood barrier.